Category Archives: Biotech

Biotech (channel) Breakdown

September 15, 2026 By in $SPSIBI, Biotech, IBB, IBB-26-05, SPBIO, XBI, XBI-26-11 Leave a comment

Off The Cliff?

We won’t know for sure, until a long time from now … when it’s all over (not advice, not a recommendation).

Yesterday’s action in biotech IBB, posted a new daily high, while at the same time, XBI moved higher but was unable to post a new high.

Trade Action: IBB-26-05, was exited with profit and the short re-established as XBI-26-11 (not advice, not a recommendation).

As the chart shows (blue arrows), that XBI short was increased during today’s session.

Biotech XBI, Daily

We’re still at the far-right side, the ‘supply side’.

If the entire channel is in-effect, the ‘demand side’, is a long way away.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech in ‘Sequence’

September 11, 2026 By in Biotech, IBB, SPBIO, $SPSIBI, IBB-26-05 Leave a comment

Fibonacci Sequence

As far as the markets are concerned, when ‘everybody’ figures out there’s a pattern going on, that pattern morphs into something else.

For now, as the chart shows, it looks like biotech IBB, is ‘respecting’ a Fibonacci sequence (not advice, not a recommendation).

The chart also shows a potential channel.

Biotech IBB, Daily

So far, IBB is pivoting right at, or adjacent to sequence numbers (not advice, not a recommendation).

Next up, would be number ’21’.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech follows Amgen … Down

September 8, 2026 By in $SPSIBI, AMGN, Biotech, IBB, IBB-26-05, SPBIO, XBI, XBI-26-10 Leave a comment

IBB, Below Support

Amgen was whacked for a -10.08% loss during today’s session.

Biotech IBB, XBI, followed suit; down -2.17% and -1.15%, respectively.

Both indexes retraced during the day; it was noted XBI’s retrace was 50%, while IBB’s retrace as 38%.

Therefore, the trading response was to close short-trade XBI-26-10 (for profit), re-establish that short via IBB, as IBB-26-05 (not advice, not a recommendation).

Note in the chart above, the last time IBB pushed below support, it was in spring position and moved higher the next three sessions.

Markets tend to alternate.

Let’s see what happens next.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Moderna ‘Stretched’

September 5, 2026 By in Biotech, MRNA, SPBIO, XBI, XBI-26-10 Leave a comment

The Most, Ever

The effect of Moderna’s single day +176.97% move, can be directly seen in biotech XBI gaining +5.90%, the same day.

Since then, it’s been just over two-weeks and already, Wall St. has ‘cooled‘ to Moderna.

You can’t make this up. 🙂

With that said, and from a market behavior standpoint alone, wide high-volume price bars, tend to be tested (not advice, not a recommendation).

Moderna MRNA, Weekly

With MRNA slamming into resistance, highest volume, widest bar, ever, sort of says ‘Ruh Roh‘.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech (short) Close-Up

September 4, 2026 By in Biotech, XBI, XBI-26-10 Leave a comment

Documenting The Trade

Yesterday’s trade was a stretch to go short on biotech XBI, without (confirmation) posting a new daily low (yet),

Today, the new daily low … just barely.

What that does from a trading standpoint, is provide a definitive stop; yesterday’s high (not advice, not a recommendation).

From the chart, we’re at the edge of congestion with price action struggling to make new highs … that so far, are not happening.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech at The Edge (again)

September 3, 2026 By in $SPSIBI, ABNB, Biotech, CVNA, KMX, LABD, LABD-26-10, SPBIO, XBI, XBI-26-10 1 Comment

Is The Top, In?

Whether it’s Biotech XBI, Airbnb, CarMax or Carvana, trade set-ups are being worked that take place at the ‘edge of congestion.’

The last update on XBI, was here, August 24th, nine trading days ago.

The short, LABD-26-10 was immediately stopped out at the next session.

The index labored on, grinding in a range while posting a bearish MACD divergence on daily and weekly.

All of which, brings us to now.

The chart shows today’s action could not close above the resistance area posted back in July (not advice, not a recommendation).

There’s been no new daily low (yet).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech … Breakout Bust

August 30, 2026 By in Biotech, IBB, SPBIO

Wedge ‘Throw-Over’

‘When price action heads south, bad news comes out.’

The chart below, shows we’re at a nascent reversal (not advice, not a recommendation).

Once a reversal takes hold and the money dries up, it’s likely to get very interesting.

Popcorn at the ready. 🙂

Biotech IBB, Daily Close

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech Spotlight

August 24, 2026 By in $SPSIBI, Biotech, Ed Dowd, Greg Hunter, LABD, LABD-26-10, SPBIO, Speck-Effect, Spring-to-Up-Thrust, The Speck, XBI, ZeroHedge 1 Comment

Potential Set-Up

Over the weekend, Greg Hunter released his latest interview with Ed Dowd, link here.

ZeroHedge subsequently picked up that feed, link here.

As is typical with ZeroHedge, the comments are a veritable gold-mine. In the like above, they don’t disappoint.

With XBI, we have our repeating pattern, link here.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech … Downside Reversal?

August 16, 2026 By in Biotech, IBB, IBB-26-02, Karen Kingston, Speck-Effect, The Speck, Up-Thrust, Wyckoff

Alignment of Forces

The last two updates, here and here, presented the case, forces are lining up; probability’s increasing for a downside reversal.

This update will complete the session (so far) on that potential.

Let’s not forget, behind-the-scenes (for years) stories like this and this continue to bubble to the surface.

Biotech IBB, Weekly

Last week’s trading range was significantly more narrow (with volume higher) than the week prior.

The chart shows IBB finished at or near the top of the wedge boundary and in Wyckoff ‘up-thrust’ position.

The ‘more’ promised at the end of yesterday’s update; Friday’s daily volume contracted on the test.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech ‘Dissected’

August 15, 2026 By in Biotech, IBB, IBB-26-02 1 Comment

Looking at The Inside

Yesterday’s update showed biotech sector IBB, in a bearish divergence.

The list of components can be found here.

For today, we’ll look at some of the technical characteristics pointing to potential for a downside reversal (not advice, not a recommendation).

Biotech IBB, Weekly

A wedge typically occurs at the end of a move, whether up or down (not advice, not a recommendation).

Price action has met the ‘measured move’ target and even gone slightly above.

The potential bearish MACD is shown.

If the coming week is flat or down, we’ll (likely) have a tick lower in MACD, completing the divergence signal.

Fo the next update, we’ll discuss a much larger ‘terminating’ wedge and more.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279